Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-04-01

Clinical Trial Update: Effects of Hydroxychloroquine on Oral Complaints of Sjögren Patients

View source ↗

Summary

A completed clinical trial from Ege University evaluated whether hydroxychloroquine improves oral symptoms in patients with Sjögren's syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Ege University | Conditions: Sjögren's Syndrome, Xerostomia | Status: COMPLETED